Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Relief Therapeutics Holdings AG (QB) RLFTF

Alternate Symbol(s):  RLFTY

Healthcare Biotechnology
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.

Current News (OTCQB:RLFTF)

MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank 

ACCESS Newswire March 19, 2026

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics

ACCESS Newswire December 23, 2025

Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics

ACCESS Newswire December 15, 2025

Relief Therapeutics Shareholders Approve Business Combination with NeuroX

ACCESS Newswire November 14, 2025

Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032

ACCESS Newswire October 29, 2025

Relief Therapeutics Publishes 2025 Half-Year Report

ACCESS Newswire August 14, 2025

Relief Therapeutics Advances Publication of 2025 Half-Year Report

ACCESS Newswire August 11, 2025

Relief Therapeutics Announces Proposed Business Combination with NeuroX, Successor to MindMaze

ACCESS Newswire July 29, 2025

Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011

ACCESS Newswire June 20, 2025
View More News ››

Opinion & Analysis (OTCQB:RLFTF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCQB:RLFTF)

WHAT THE%$#(

I dont know how I ever traded without using BULLALERTS I look forward to their daily emails each morning that list pre-market movers...
wabomebuypo16 - November 2, 2022

New York To Europe, China Is The Place.To Invest! ABQQ Ceo

Just Bought Another Big Block On Open MKT. No Stock Promos And No Dillution, Low Os, Low Float....Real Biz With Real Revs!
RReis09 - February 26, 2021

bacl on RLFTF after this!!

Today is Friday the 16.October 2020 and I would like to remind you of the following: We hold the patent on RLF100 and the process for its...
TAATInvestor - October 16, 2020

RLFTF

Are you guys facing any issues to buy and sell RLFTF shares with any Canadian brokers? Thanks
johnking1234 - August 18, 2020

RE:Wowwww

so far we have a setback but hopefully it is only for a short while. Great rebound from mid .30's
teheran10 - August 17, 2020

Wowwww

Is this going to dollar land or what?
Busyzzindahouse - August 3, 2020
View more Bullboard ››

Avrupa Minerals Ltd.

Avrupa Minerals Ltd.

Avrupa Minerals Ltd., a junior exploration and development company, engages in the acquisition and exploration of mineral ...
View More »

Podcasts